EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?

In the EOLIA trial, early use of ECMO did not significantly improve mortality at 60 days in patients with severe ARDS, but when used as a rescue modality ECMO might help improve survival http://bit.ly/2XOjwSE

Detalles Bibliográficos
Autores principales: Sameed, Muhammad, Meng, Zhou, Marciniak, Ellen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717615/
https://www.ncbi.nlm.nih.gov/pubmed/31508163
http://dx.doi.org/10.1183/20734735.0363-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717615/
https://www.ncbi.nlm.nih.gov/pubmed/31508163
http://dx.doi.org/10.1183/20734735.0363-2018

Ejemplares similares